DK1556375T3 - Flavonderivater som inhibitorer af cyklinafhængige kinaser - Google Patents
Flavonderivater som inhibitorer af cyklinafhængige kinaserInfo
- Publication number
- DK1556375T3 DK1556375T3 DK03753911T DK03753911T DK1556375T3 DK 1556375 T3 DK1556375 T3 DK 1556375T3 DK 03753911 T DK03753911 T DK 03753911T DK 03753911 T DK03753911 T DK 03753911T DK 1556375 T3 DK1556375 T3 DK 1556375T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyclin
- inhibitors
- dependent kinases
- flavone derivatives
- flavone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN616MU2002 | 2002-07-08 | ||
| PCT/IN2003/000234 WO2004004632A2 (en) | 2002-07-08 | 2003-07-07 | Flavone derivatives as inhibitors of cyclin-dependent kinases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1556375T3 true DK1556375T3 (da) | 2008-11-03 |
Family
ID=30012269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03753911T DK1556375T3 (da) | 2002-07-08 | 2003-07-07 | Flavonderivater som inhibitorer af cyklinafhængige kinaser |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1556375B1 (ko) |
| JP (1) | JP4860148B2 (ko) |
| KR (1) | KR100991920B1 (ko) |
| CN (1) | CN1668613B (ko) |
| AR (1) | AR041184A1 (ko) |
| AT (1) | ATE399162T1 (ko) |
| AU (1) | AU2003272070B2 (ko) |
| BR (1) | BR0312633A (ko) |
| CA (1) | CA2492130C (ko) |
| DE (1) | DE60321808D1 (ko) |
| DK (1) | DK1556375T3 (ko) |
| ES (1) | ES2309338T3 (ko) |
| IL (1) | IL166153A (ko) |
| MX (1) | MXPA05000388A (ko) |
| NZ (1) | NZ537518A (ko) |
| PT (1) | PT1556375E (ko) |
| RU (1) | RU2334746C2 (ko) |
| TW (1) | TWI331034B (ko) |
| WO (1) | WO2004004632A2 (ko) |
| ZA (1) | ZA200500138B (ko) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7915301B2 (en) | 2002-07-08 | 2011-03-29 | Piramal Life Science Limited | Inhibitors of cyclin dependent kinases and their use |
| ES2491140T3 (es) * | 2006-06-21 | 2014-09-05 | Piramal Enterprises Limited | Derivados de flavona enantioméricamente puros para el tratamiento de trastornos proliferativos y procesos para su preparación |
| US7951961B2 (en) * | 2006-07-07 | 2011-05-31 | Piramal Life Sciences Limited | Enantioselective synthesis of pyrrolidines substituted with flavones, and intermediates thereof |
| EP2154971B1 (en) * | 2007-05-15 | 2011-12-28 | Piramal Life Sciences Limited | A synergistic pharmaceutical combination for the treatment of cancer |
| CN101333205A (zh) * | 2008-07-10 | 2008-12-31 | 大连理工大学 | 周期素依赖蛋白激酶抑制剂黄芩素哌嗪衍生物及其制法 |
| TWI461194B (zh) | 2009-05-05 | 2014-11-21 | Piramal Entpr Ltd | 吡咯啶取代黃酮作為輻射致敏劑 |
| EP2429292B1 (en) * | 2009-05-08 | 2019-04-03 | Georgia State University Research Foundation | Compounds and compositions comprising cdk inhibitors and their use in the treatment of cancer |
| US7928067B2 (en) | 2009-05-14 | 2011-04-19 | Ischemix Llc | Compositions and methods for treating ischemia and ischemia-reperfusion injury |
| CN103037860A (zh) * | 2010-02-26 | 2013-04-10 | 皮拉马尔企业有限公司 | 用于治疗炎症性疾病的吡咯烷取代的黄酮 |
| US8815937B2 (en) | 2010-11-18 | 2014-08-26 | Ischemix Llc | Lipoyl compounds and their use for treating ischemic injury |
| WO2012069972A1 (en) | 2010-11-19 | 2012-05-31 | Piramal Life Sciences Limited | A pharmaceutical combination for the treatment of breast cancer |
| CN104220066A (zh) * | 2010-11-19 | 2014-12-17 | 皮拉马尔企业有限公司 | 紫杉醇和cdk抑制剂药物组合物 |
| TW201242597A (en) | 2011-03-14 | 2012-11-01 | Piramal Life Sciences Ltd | A synergistic pharmaceutical combination for the treatment of pancreatic cancer |
| US8530470B2 (en) * | 2011-04-13 | 2013-09-10 | Astrazeneca Ab | Chromenone derivatives |
| TW201300105A (zh) * | 2011-05-31 | 2013-01-01 | Piramal Life Sciences Ltd | 治療頭頸鱗狀細胞癌之相乘藥物組合物 |
| JP2014517063A (ja) | 2011-06-24 | 2014-07-17 | ピラマル エンタープライジーズ リミテッド | ヒトパピローマウイルスと関連するがんを処置するための化合物 |
| IN2014MN01546A (ko) | 2012-01-13 | 2015-05-08 | Piramal Entpr Ltd | |
| WO2014049515A1 (en) * | 2012-09-25 | 2014-04-03 | Piramal Enterprises Limited | Pyrrolidine substituted flavones for treatment of renal cystic diseases |
| CA2917742C (en) * | 2013-07-12 | 2020-04-14 | Piramal Enterprises Limited | A pharmaceutical combination for the treatment of melanoma |
| EP3148532B1 (en) | 2014-05-28 | 2021-03-03 | Piramal Enterprises Limited | Pharmaceutical combination comprising a cdk inhibitor and a thioredoxin reductase inhibitor for the treatment of cancer |
| EP3313827B1 (de) * | 2015-06-23 | 2019-11-06 | Covestro Deutschland AG | Substituierte triazine |
| JP7114478B2 (ja) | 2016-03-28 | 2022-08-08 | プレサージュ バイオサイエンシズ，インコーポレイテッド | 癌の治療のための配合剤 |
| CA3040815C (en) | 2016-10-20 | 2021-07-20 | Steven Martin Evans | Anti-proliferative agents for treating pah |
| JP7203756B2 (ja) | 2017-04-25 | 2023-01-13 | イスケミックス エルエルシー | 外傷性脳傷害を治療するための組成物および方法 |
| CN107573270B (zh) * | 2017-09-29 | 2019-11-29 | 河南师范大学 | 一种α-甲酰基吡咯烷类化合物的合成方法 |
| US11993591B2 (en) | 2018-10-19 | 2024-05-28 | Hoffmann-La Roche Inc. | Chromen-4-one derivatives for the treatment and prophylaxis of hepatitis B virus disease |
| CN110028475B (zh) * | 2019-05-13 | 2022-07-01 | 中国药科大学 | 基于苯并吡喃结构的新型cdk9抑制剂、其制备方法及应用 |
| AR121719A1 (es) | 2020-04-03 | 2022-06-29 | Petra Pharma Corp | Inhibidores alostéricos de cromenona del fosfoinosítido 3-quinasa (pi3k) para el tratamiento de enfermedades |
| AU2022268900A1 (en) | 2021-05-03 | 2023-11-16 | Petra Pharma Corporation | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease |
| TWI829179B (zh) | 2021-05-27 | 2024-01-11 | 美商佩特拉製藥公司 | 用於治療疾病之磷酸肌醇3-激酶(pi3k)異位色烯酮抑制劑 |
| CN113549044B (zh) * | 2021-07-23 | 2024-01-23 | 中国药科大学 | 8-氮杂环取代色酮类衍生物及其制备方法与制药用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3836676A1 (de) * | 1988-10-28 | 1990-05-03 | Hoechst Ag | Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel |
| US5733920A (en) * | 1995-10-31 | 1998-03-31 | Mitotix, Inc. | Inhibitors of cyclin dependent kinases |
| US5849733A (en) * | 1996-05-10 | 1998-12-15 | Bristol-Myers Squibb Co. | 2-thio or 2-oxo flavopiridol analogs |
| CN1433410A (zh) * | 2000-05-03 | 2003-07-30 | 株式会社Lg生命科学 | 具有3－羟基色烯－4－酮结构的cdk抑制剂 |
-
2003
- 2003-06-24 TW TW092117185A patent/TWI331034B/zh not_active IP Right Cessation
- 2003-07-04 AR ARP030102432A patent/AR041184A1/es unknown
- 2003-07-07 AU AU2003272070A patent/AU2003272070B2/en not_active Ceased
- 2003-07-07 EP EP03753911A patent/EP1556375B1/en not_active Expired - Lifetime
- 2003-07-07 DK DK03753911T patent/DK1556375T3/da active
- 2003-07-07 PT PT03753911T patent/PT1556375E/pt unknown
- 2003-07-07 AT AT03753911T patent/ATE399162T1/de active
- 2003-07-07 DE DE60321808T patent/DE60321808D1/de not_active Expired - Lifetime
- 2003-07-07 KR KR1020057000401A patent/KR100991920B1/ko not_active IP Right Cessation
- 2003-07-07 NZ NZ537518A patent/NZ537518A/en not_active IP Right Cessation
- 2003-07-07 RU RU2005102939/04A patent/RU2334746C2/ru not_active IP Right Cessation
- 2003-07-07 MX MXPA05000388A patent/MXPA05000388A/es active IP Right Grant
- 2003-07-07 JP JP2004519151A patent/JP4860148B2/ja not_active Expired - Lifetime
- 2003-07-07 BR BR0312633-1A patent/BR0312633A/pt not_active IP Right Cessation
- 2003-07-07 CN CN038163241A patent/CN1668613B/zh not_active Expired - Lifetime
- 2003-07-07 CA CA2492130A patent/CA2492130C/en not_active Expired - Fee Related
- 2003-07-07 WO PCT/IN2003/000234 patent/WO2004004632A2/en active IP Right Grant
- 2003-07-07 ES ES03753911T patent/ES2309338T3/es not_active Expired - Lifetime
-
2005
- 2005-01-05 IL IL166153A patent/IL166153A/en active IP Right Grant
- 2005-01-06 ZA ZA200500138A patent/ZA200500138B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR041184A1 (es) | 2005-05-04 |
| RU2334746C2 (ru) | 2008-09-27 |
| CN1668613B (zh) | 2012-07-04 |
| JP2006502109A (ja) | 2006-01-19 |
| ATE399162T1 (de) | 2008-07-15 |
| KR100991920B1 (ko) | 2010-11-04 |
| IL166153A (en) | 2009-11-18 |
| MXPA05000388A (es) | 2005-09-30 |
| PT1556375E (pt) | 2008-10-03 |
| ZA200500138B (en) | 2006-02-22 |
| IL166153A0 (en) | 2006-01-15 |
| TW200406202A (en) | 2004-05-01 |
| WO2004004632A2 (en) | 2004-01-15 |
| EP1556375B1 (en) | 2008-06-25 |
| CA2492130C (en) | 2011-09-06 |
| BR0312633A (pt) | 2005-07-19 |
| ES2309338T3 (es) | 2008-12-16 |
| EP1556375A2 (en) | 2005-07-27 |
| KR20050017110A (ko) | 2005-02-21 |
| JP4860148B2 (ja) | 2012-01-25 |
| AU2003272070A1 (en) | 2004-01-23 |
| CA2492130A1 (en) | 2004-01-15 |
| CN1668613A (zh) | 2005-09-14 |
| WO2004004632A3 (en) | 2004-09-16 |
| TWI331034B (en) | 2010-10-01 |
| RU2005102939A (ru) | 2005-09-10 |
| AU2003272070B2 (en) | 2009-02-26 |
| DE60321808D1 (de) | 2008-08-07 |
| NZ537518A (en) | 2008-02-29 |
| WO2004004632A8 (en) | 2005-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1556375T3 (da) | Flavonderivater som inhibitorer af cyklinafhængige kinaser | |
| DK1463506T3 (da) | Substituerede quinazolin-derivater som inhibitorer af aurora-kinaser | |
| DK1562589T3 (da) | Diaminotriazoler der er nyttige som inhibitorer af proteinkinaser | |
| DK1585749T3 (da) | Diazepinoindol-derivater som kinaseinhibitorer | |
| SE0502338L (sv) | Azaspiroalkanderivat som hämmare av metalloproteaser | |
| NO20045220L (no) | Heterocykliske inhibitorer for kinaser | |
| DK1664043T3 (da) | Sammensætninger egnede som inhibitorer af proteinkinaser | |
| DK1581515T3 (da) | Triazolderivater som inhibitorer af 11-beta-hydroxysteroid-dehydrogenase-1 | |
| DK1532138T3 (da) | Inhibitorer af tyrosinkinaser | |
| DK1720882T3 (da) | Pyrazolopyrimidin-derivater som cyclin-afhængige kinaseinhibitorer | |
| DK1492785T3 (da) | 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer | |
| DK1686999T3 (da) | Pyrazolderivater som inhibitorer af receptortyrosinkinaser | |
| DK1480962T3 (da) | 5-Phenylthiazol-derivater og deres anvendelse som P1-3-kinaseinhibitorer | |
| DK1786799T3 (da) | Hidtil ukendte phenylaminopyrimidinderivater som inhibitorer af bcr-abl-kinase | |
| DK1438306T3 (da) | Derivater af UK-2A | |
| NO20023828L (no) | Pyrimidin-4-on derivater som LDL-PLA2 inhibitorer | |
| NO20043726L (no) | Heteroarylforbindelser anvendelige som inhibitorer av GSK-3 | |
| NO20050072L (no) | Nye inhibitorer av kinaser | |
| DK1944305T3 (da) | Quinolinderivater som phosphodiesteraseinhibitorer | |
| NO20050665L (no) | Pyrrolidonderivater som MAOE inhibitoere | |
| DK1562902T3 (da) | 2-pyridonderivater som inhibitorer af neutrofilelastase | |
| DK2039685T3 (da) | Heterobicycliske forbindelser som P38-inhibitorer | |
| DK1658292T3 (da) | Triazologyrimidinderivater som glycogensynthasekinase 3 - inhibitorer | |
| DK1811998T3 (da) | Triazoler anvendelige som inhibitorer af proteinkinaser | |
| DK1763517T3 (da) | Pyrimidinderivater som 11beta-HSD1-inhibitorer |